Global Immunoglobulin Market By Product Overview
The Immunoglobulin market accounted for US$ 9.23 billion in 2020 and is estimated to be US$ 16.62 billion by 2030 and is anticipated to register a CAGR of 6.1%.
Immunoglobulins are also known as antibodies, which are glycoprotein molecules produced by plasma cells. Immunoglobulin acts as critical part of immune response by specifically recognizing and binding to particular antigens, such as bacteria or viruses. Different classes of immunoglobulin include IgG, IgA, and IgM. Various immunological and neurological diseases can be treated by using these classes of immunoglobulin. This immunoglobulin’s can be administered intravenously and subcutaneously. The increasing application of immunoglobulin is gaining significant traction among pharmaceutical and biopharmaceutical companies for research and development.
Global Immunoglobulin Market By Product Dynamics
Increasing number of product launch
Furthermore, increasing number of product launch and clinical trials for new clinical applications is major factor expected to boost growth of the immunoglobulin market in the near future. Moreover, increasing incidences of primary immunodeficiency disease across the globe is also some among the major drivers for the immunoglobulin market.
The increasing number of geriatric population, which is more prone to develop disease due to low antibody immune response of body, is another factor propelling demand for immunoglobulin. However, stringent regulatory scenario, high cost of treatment, and emergence of alternative therapies is expected hamper growth of the immunoglobulin market in the near future.
Global Immunoglobulin Market By Product Segmentation
immunoglobulin market is segmented on the basis of product, mode of delivery, and geography.
On the basis of product, the immunoglobulin market has been segmented into IgG, IgA, IgM, IgE, and IgD. On the basis of mode of delivery the immunoglobulins market is segmented into intravenous, and subcutaneous. On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.
Regional Insights:
On the basis of region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the market, followed by Europe during the forecast year due to growing aging population and stringent regulations in this region are the major factors driving the growth of the Immunoglobulin industry in North America.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Product- IgG, IgA, IgM, IgE, and IgD By Mode of delivery- Intravenous, And Subcutaneous |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Immunoglobulin market report based on product, mode of delivery and region.
Global Immunoglobulin Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- U.S.
- Canada
- Middle East & Africa
Global Immunoglobulin Market By Product Key Players
Key players operating in the immunoglobulin market includes Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare.
Global Immunoglobulin Market By Product Company Profile
- Baxter international Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- CSL Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Grifols S.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Octapharma AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Kedrion Biopharma Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- LFB group
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Biotest AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- China Biologics Products Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- BDI Pharma Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bayer Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Immunoglobulin Market By Product Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Immunoglobulin Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Mode of delivery
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- IgG
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- IgA
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- IgM
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- IgE
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- IgD
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Mode of delivery, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Intravenous
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Subcutaneous
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of delivery, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of delivery, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of delivery, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of delivery, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of delivery, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Baxter international Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- CSL Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Grifols S.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Octapharma AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Kedrion Biopharma Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- LFB group
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Biotest AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- China Biologics Products Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- BDI Pharma Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bayer Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
Global Immunoglobulin Market is segmented by Product (IgG, IgA, IgM, IgE, and IgD), by Mode of Delivery (Intravenous and Subcutaneous), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
This immunoglobulin’s can be administered intravenously and subcutaneously. The increasing application of immunoglobulin is gaining significant traction among pharmaceutical and biopharmaceutical companies for research and development. Furthermore, increasing number of product launch and clinical trials for new clinical applications is major factor expected to boost growth of the global immunoglobulins market in the near future.
North America dominates the market of global Immunoglobulin over forecast period.
Key players operating in the global immunoglobulin market includes Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare.